ArticleBMJ open2019

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study.

Oliver Hendricks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.